Literature DB >> 32560099

Temperament and Character Profile and Its Clinical Correlates in Male Patients with Dual Schizophrenia.

Laura Río-Martínez1,2, Julia E Marquez-Arrico1, Gemma Prat1, Ana Adan1,2.   

Abstract

Personality traits are relevant in understanding substance use disorders (SUD) and schizophrenia (SZ), but few works have also included patients with dual schizophrenia (SZ+) and personality traits. We explored personality profile in a sample of 165 male patients under treatment, using the Temperament and Character Inventory-Revised. The participants were assigned to three groups of 55 patients each, according to previous diagnosis: SUD, SZ- and SZ+ (without/with SUD). We analyzed their clinical characteristics, relating them to personality dimensions. The SUD and SZ+ groups scored higher than SZ- in Novelty/Sensation Seeking. SZ- and SZ+ presented higher Harm Avoidance and lower Persistence than the SUD group. SZ+ patients showed the lowest levels of Self-directedness, while SZ- and SZ+ had higher scores in Self-transcendence than the SUD group. Several clinical characteristics were associated with personality dimensions depending on diagnosis, and remarkably so for psychiatric symptoms in the SZ- and SZ+ groups. The three groups had a maladaptive personality profile compared to general population. Our results point to different profiles for SUD versus SZ, while both profiles appear combined in the SZ+ group, with extreme scores in some traits. Thus, considering personality endophenotypes in SZ+ could help in designing individualized interventions for this group.

Entities:  

Keywords:  character; dual schizophrenia; global functioning; personality; psychiatric symptoms; schizophrenia; substance use disorder; temperament

Year:  2020        PMID: 32560099     DOI: 10.3390/jcm9061876

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  1 in total

1.  Dual Diagnosis in Adolescents with Problematic Use of Video Games: Beyond Substances.

Authors:  Arturo Esteve; Antonio Jovani; Ana Benito; Abel Baquero; Gonzalo Haro; Francesc Rodríguez-Ruiz
Journal:  Brain Sci       Date:  2022-08-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.